CLLS
Cellectis

2,606
Mkt Cap
$376.33M
Volume
219,268.00
52W High
$5.48
52W Low
$1.10
PE Ratio
-15.66
CLLS Fundamentals
Price
$5.22
Prev Close
$5.13
Open
$5.15
50D MA
$4.09
Beta
1.15
Avg. Volume
132,065.26
EPS (Annual)
-$0.4052
P/B
5.21
Rev/Employee
$186,629.20
Loading...
Loading...
News
all
press releases
Cellectis (NASDAQ:CLLS) Share Price Crosses Above Fifty Day Moving Average - Here's Why
Cellectis (NASDAQ:CLLS) Stock Passes Above Fifty Day Moving Average - Should You Sell...
MarketBeat·15d ago
News Placeholder
More News
News Placeholder
Why Cellectis Stock Is Trading Higher Today
Cellectis reports strong Nature Communications data showing CssDNA boosts non-viral gene insertion efficiency and supports long-term therapeutic potential.read more...
Benzinga·22d ago
News Placeholder
Cellectis (NASDAQ:CLLS) Shares Cross Above Fifty Day Moving Average - Should You Sell?
Cellectis (NASDAQ:CLLS) Stock Crosses Above 50 Day Moving Average - Here's Why...
MarketBeat·23d ago
News Placeholder
Cellectis (NASDAQ:CLLS) Posts Earnings Results, Beats Estimates By $0.11 EPS
Cellectis (NASDAQ:CLLS - Get Free Report) posted its quarterly earnings data on Friday. The biotechnology company reported $0.01 earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat·1mo ago
News Placeholder
Cellectis Earnings Preview
read more...
Benzinga·1mo ago
News Placeholder
This Penny Stock Has 270% Upside Potential in 2025. Is It a Buy Now?
Shares of this biotech company have had a rough ride in 2024, but analysts are feeling good about its future.
barchart.com·11mo ago

Latest CLLS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.